Peru vs South America: Proportion of the target population who received the final dose of
Peru
97.0%
in 2024
South America
69.0%
in 2024
Peru rank
3rd
South America rank
4th
Proportion of the target population who received the final dose of over time
- Peru
- South America
How they compare
Peru currently reports 97.0% against 69.0% in South America, a difference of 28.0%.
That makes Peru's figure about 1.4 times South America's.
The two have swapped places 6 times across 14 shared years of data; in 2011 it was Peru ahead.
Peru ranks 3rd and South America ranks 4th of 107 countries.
Across the 2 decades both report, Peru averaged higher in 1 and South America in 1.
Head to head by decade
| Decade | Peru | South America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 40.4% | 38.8% | 1.7% | Peru |
| 2020s | 53.2% | 54.4% | 1.2% | South America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Peru or South America?
- Peru, at 97.0% against 69.0% in South America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Peru and South America?
- 28.0%, with Peru ahead.
- How many years of comparable data are there for Peru and South America?
- 14 years are reported by both, from 2011 to 2024.
- How do Peru and South America rank globally for proportion of the target population who received the final dose of?
- Peru ranks 3rd and South America ranks 4th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.